PM Pharma ApS: Financial statements 2023
CVR: 42988197
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PM Pharma ApS (CVR 42988197) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,498,090 and a net result of DKK 27,036 compared with DKK 187,612 the year before. That is an increase of 147.9% compared with the year before. Equity in the 2023 report amounted to DKK 164,648. The solvency ratio was 16.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,498,090
- Profit/Loss
- DKK 27,036
- Equity
- DKK 164,648
- Total Assets
- DKK 995,903
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.5 mio. | 27 t. | 165 t. | 3 |
| 2022 | - | 1 mio. | 188 t. | 228 t. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PM Pharma ApS has published its annual report for 2022. Gross profit came to DKK 1,007,879, and the net result was DKK 187,612.
About PM Pharma ApS
PM Pharma ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2022. The company is registered under the industry Installation af industrimaskiner og -udstyr. The management consists of Patrick Munck. The company is owned by PM Engineering ApS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 3,220,588 and a net result of DKK -19,580 compared with DKK 6,341 the year before. Equity in the 2025 report amounted to DKK 151,479.